These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 15339912)

  • 1. Divergent effects of peroxisome proliferator-activated receptor gamma agonists and tumor necrosis factor alpha on adipocyte ApoE expression.
    Yue L; Rasouli N; Ranganathan G; Kern PA; Mazzone T
    J Biol Chem; 2004 Nov; 279(46):47626-32. PubMed ID: 15339912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor {gamma} stimulation of adipocyte ApoE gene transcription mediated by the liver receptor X pathway.
    Yue L; Mazzone T
    J Biol Chem; 2009 Apr; 284(16):10453-61. PubMed ID: 19218241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic changes of adiponectin and S100A8 levels by the selective peroxisome proliferator-activated receptor-gamma agonist rivoglitazone.
    Hiuge-Shimizu A; Maeda N; Hirata A; Nakatsuji H; Nakamura K; Okuno A; Kihara S; Funahashi T; Shimomura I
    Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):792-9. PubMed ID: 21233451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trichostatin A modulates thiazolidinedione-mediated suppression of tumor necrosis factor α-induced lipolysis in 3T3-L1 adipocytes.
    Lu JC; Chang YT; Wang CT; Lin YC; Lin CK; Wu ZS
    PLoS One; 2013; 8(8):e71517. PubMed ID: 23951179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcription suppression of peroxisome proliferator-activated receptor gamma2 gene expression by tumor necrosis factor alpha via an inhibition of CCAAT/ enhancer-binding protein delta during the early stage of adipocyte differentiation.
    Kudo M; Sugawara A; Uruno A; Takeuchi K; Ito S
    Endocrinology; 2004 Nov; 145(11):4948-56. PubMed ID: 15284209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potential of the dual peroxisome proliferator activated receptor (PPAR)α/γ agonist aleglitazar in attenuating TNF-α-mediated inflammation and insulin resistance in human adipocytes.
    Massaro M; Scoditti E; Pellegrino M; Carluccio MA; Calabriso N; Wabitsch M; Storelli C; Wright M; De Caterina R
    Pharmacol Res; 2016 May; 107():125-136. PubMed ID: 26976796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pioglitazone induces apoptosis of macrophages in human adipose tissue.
    Bodles AM; Varma V; Yao-Borengasser A; Phanavanh B; Peterson CA; McGehee RE; Rasouli N; Wabitsch M; Kern PA
    J Lipid Res; 2006 Sep; 47(9):2080-8. PubMed ID: 16799131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptor-gamma regulates the expression and function of very-low-density lipoprotein receptor.
    Tao H; Aakula S; Abumrad NN; Hajri T
    Am J Physiol Endocrinol Metab; 2010 Jan; 298(1):E68-79. PubMed ID: 19861583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosiglitazone induction of Insig-1 in white adipose tissue reveals a novel interplay of peroxisome proliferator-activated receptor gamma and sterol regulatory element-binding protein in the regulation of adipogenesis.
    Kast-Woelbern HR; Dana SL; Cesario RM; Sun L; de Grandpre LY; Brooks ME; Osburn DL; Reifel-Miller A; Klausing K; Leibowitz MD
    J Biol Chem; 2004 Jun; 279(23):23908-15. PubMed ID: 15073165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha.
    Zhang B; Berger J; Hu E; Szalkowski D; White-Carrington S; Spiegelman BM; Moller DE
    Mol Endocrinol; 1996 Nov; 10(11):1457-66. PubMed ID: 8923470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor-alpha-mediated suppression of adipocyte apolipoprotein E gene transcription: primary role for the nuclear factor (NF)-kappaB pathway and NFkappaB p50.
    Yue L; Christman JW; Mazzone T
    Endocrinology; 2008 Aug; 149(8):4051-8. PubMed ID: 18467438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E gene expression in mouse 3T3-L1 adipocytes and human adipose tissue and its regulation by differentiation and lipid content.
    Zechner R; Moser R; Newman TC; Fried SK; Breslow JL
    J Biol Chem; 1991 Jun; 266(16):10583-8. PubMed ID: 1709937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A selective peroxisome proliferator-activated receptor gamma modulator with distinct fat cell regulation properties.
    Fujimura T; Kimura C; Oe T; Takata Y; Sakuma H; Aramori I; Mutoh S
    J Pharmacol Exp Ther; 2006 Aug; 318(2):863-71. PubMed ID: 16682454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stage-specific effects of a thiazolidinedione on proliferation, differentiation and PPARgamma mRNA expression in 3T3-L1 adipocytes.
    Takamura T; Nohara E; Nagai Y; Kobayashi K
    Eur J Pharmacol; 2001 Jun; 422(1-3):23-9. PubMed ID: 11430909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pioglitazone ameliorates tumor necrosis factor-alpha-induced insulin resistance by a mechanism independent of adipogenic activity of peroxisome proliferator--activated receptor-gamma.
    Iwata M; Haruta T; Usui I; Takata Y; Takano A; Uno T; Kawahara J; Ueno E; Sasaoka T; Ishibashi O; Kobayashi M
    Diabetes; 2001 May; 50(5):1083-92. PubMed ID: 11334412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of PPARalpha activation of macrophages on the secretion of inflammatory cytokines in cultured adipocytes.
    Murakami K; Bujo H; Unoki H; Saito Y
    Eur J Pharmacol; 2007 Apr; 561(1-3):206-13. PubMed ID: 17320860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thiazolidinedione- and tumor necrosis factor alpha-induced downregulation of peroxisome proliferator-activated receptor gamma mRNA in differentiated 3T3-L1 adipocytes.
    Perrey S; Ishibashi S; Yahagi N; Osuga J; Tozawa R; Yagyu H; Ohashi K; Gotoda T; Harada K; Chen Z; Iizuka Y; Shionoiri F; Yamada N
    Metabolism; 2001 Jan; 50(1):36-40. PubMed ID: 11172472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Very low density lipoprotein receptor promotes adipocyte differentiation and mediates the proadipogenic effect of peroxisome proliferator-activated receptor gamma agonists.
    Tao H; Hajri T
    Biochem Pharmacol; 2011 Dec; 82(12):1950-62. PubMed ID: 21924248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pioglitazone upregulates adiponectin receptor 2 in 3T3-L1 adipocytes.
    Kudoh A; Satoh H; Hirai H; Watanabe T
    Life Sci; 2011 Jun; 88(23-24):1055-62. PubMed ID: 21514306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of pioglitazone on suppressor of cytokine signaling 3 expression: potential mechanisms for its effects on insulin sensitivity and adiponectin expression.
    Kanatani Y; Usui I; Ishizuka K; Bukhari A; Fujisaka S; Urakaze M; Haruta T; Kishimoto T; Naka T; Kobayashi M
    Diabetes; 2007 Mar; 56(3):795-803. PubMed ID: 17327450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.